New paper from our group!


As a collaborative project of several groups with complementary expertise, we report the discovery of SW-101, a new HDAC6 inhibitor with markedly improved metabolic stability and druglike properties that counteracts progressive motor dysfunction and ameliorates neuropathic symptoms in a mouse model of Charcot-Marie-Tooth Type 2A disease. Congrat to all co-authors on the excellent job!